About Company
- Legal Name: Xellia Pharmaceuticals ApS
- Registered country: Denmark
- Address: Dalslandsgade 11, Copenhagen
- Number of employees: 1000 - 4999
Description:
Xellia Pharmaceuticals is the global leader in fermentation-based non-beta-lactam anti-infectives, manufacturing and supplying APIs as well as finished dosage forms (FDFs) to 500 pharmaceutical companies across 80 countries.
Business Activities
Active Pharmaceutical Ingredients (APIs)
ManufacturerDistributorContract ManufacturerAPI Manufacturer
Finished Dosage Forms
ManufacturerDistributorContract ManufacturerAPI ManufacturerMarketing Authorization Holder
Laboratory & Analytical Services
ManufacturerDistributorContract ManufacturerAPI Manufacturer
Innovator APIs
ManufacturerDistributorContract ManufacturerAPI Manufacturer
Key Products/Services
- Active Pharmaceutical Ingredients (APIs): Active Pharmaceutical Ingredients (APIs)
- Finished Dosage Forms: Polymyxin B vials, Daptomycin, Colistimethate sodium dry-filled vials, Colistimethate sodium lyophilized vials, Daptomycin RT, Anti-infective finished dosage forms
- Biological & Fermentation Ingredients: Fermentation-based manufacturing
- Innovator APIs: POLYMYXIN B SULFATE, Amphotericin B, Bacitracin, Bacitracin zinc, Colistimethate sodium (CMS), Gramicidin, Tobramycin sulfate, Tyrothricin, Vancomycin hydrochloride (manufactured in Budapest, Hungary), Vancomycin hydrochloride (manufactured in Copenhagen, Denmark), Vancomycin hydrochloride (manufactured in Taizhou, China), Daptomycin vials
Our Products & Services
Certifications
FDA
GMP
ISO
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment